2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Thursday, June 8, 2017

1:15pm-2:45pm: Disease modeling for Perry syndrome using patient induced pluripotent stem cells

T. Mishima, T. Ishikawa, K. Imamura, T. Kondo, Y. Koshiba, R. Takahashi, J. Takahashi, A. Watanabe, N. Fujii, Y. Tsuboi, H. Inoue (Fukuoka, Japan)

Other · Exhibit Hall C

1:15pm-2:45pm: Disease severity is not predictive of the dose required for apomorphine sublingual film (APL-130277) to convert a patient with Parkinson’s disease(PD) from OFF to fully ON: Preliminary Results from a Phase III Study

H. Fernandez, S. Isaacson, A. Espay, R. Pahwa, D. Truong, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro, R. Hauser (Cleveland, OH, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Disease-modifying effect of Zonisamide with the induction of BDNF and TrkB expression

N. Kanzato (Haebaru-cho, Japan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Disrupted superior collicular activity may reveal cervical dystonia disease pathomechanisms

E. Mc Govern, O. Killian, S. Narasimham, B. Quinlivan, I. Beiser, L. Williams, R. Beck, J. Butler, S. O'Riordan, R. Reilly, M. Hutchinson (Dublin, Ireland)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: Distinct pattern of striatal dopaminergic depletion in patients with parkin mutation

K.-Y. Kwon (Seoul, Republic of Korea)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Does smoking impact dopamine neuronal loss in de novo Parkinson’s disease?

Y. Lee, H.s. Yoo, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Does the side of onset affect motor and non-motor symptoms in Parkinson’s disease?

J. Silva, A. D'Abreu (Campinas, Brazil)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease

M. Gilat, P. Bell, K. Ehgoetz Martens, M. Georgiades, J. Hall, C. Walton, S. Lewis, J. Shine (Sydney, Australia)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Dopamine Normalizes Putamen to Insula Activation Shift During Choice Reaction Time Task in PD

J. Kim, K. Zhang, S. YorkWilliams, M. Ua Cruadhlaoich, V. Menon, K. Poston (Palo Alto, CA, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Dopamine transporter imaging predicts motor response to dopaminergic therapy for patients with advanced Parkinson’s disease: Possible role in patient selection for subthalamic deep brain stimulation.

A. Nakajima, Y. Shimo, S. Sekimoto, K. Kamagata, J. Takayuki, G. Oyama, A. Umemura, N. Hattori (Tokyo, Japan)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C